{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:22:37Z","timestamp":1789694557167,"version":"4.0.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s12640-017-9841-7","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T04:45:14Z","timestamp":1512967514000},"page":"702-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys"],"prefix":"10.1007","volume":"33","author":[{"given":"M.","family":"Feher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gaszner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Gil-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fernandez-Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Reglodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"issue":"6","key":"9841_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/gerona\/glu116","volume":"70","author":"E Banki","year":"2015","unstructured":"Banki E, Sosnowska D, Tucsek Z, Gautam T, Toth P, Tarantini S, Tamas A, Helyes Z, Reglodi D, Sonntag WE, Csiszar A, Ungvari Z (2015) Age-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells. J Gerontol A Biol Sci Med Sci 70(6):665\u2013674. https:\/\/doi.org\/10.1093\/gerona\/glu116","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"9841_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.parkreldis.2005.05.006","volume":"11","author":"C Barcia","year":"2005","unstructured":"Barcia C, de Pablos V, Bautista-Hern\u00e1ndez V, S\u00e1nchez-Bahillo A, Bernal I, Fern\u00e1ndez-Villalba E, Mart\u00edn J, Ba\u00f1\u00f3n R, Fern\u00e1ndez-Barreiro A, Herrero MT (2005) Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration. Parkinsonism Relat Disord 11(7):435\u2013439. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.05.006","journal-title":"Parkinsonism Relat Disord"},{"issue":"1-2","key":"9841_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2013.05.001","volume":"261","author":"C Barcia","year":"2013","unstructured":"Barcia C, Ros CM, Ros-Bernal F, Gomez A, Annese V, Carrillo-de Sauvage MA, Yuste JE, Campuzano CM, de Pablos V, Fern\u00e1ndez-Villalba E, Herrero MT (2013) Persistent phagocytic characteristics of microglia in the substantia nigra of long-term parkinsonian macaques. J Neuroimmunol 261(1-2):60\u201366. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.05.001","journal-title":"J Neuroimmunol"},{"issue":"1","key":"9841_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12640-016-9618-4","volume":"30","author":"M Bortolanza","year":"2016","unstructured":"Bortolanza M, Bariotto-Dos-Santos KD, Dos-Santos-Pereira M, da Silva CA, Del-Bel E (2016) Antidyskinetic effect of 7-nitroindazole and sodium nitroprusside associated with amantadine in a rat model of Parkinson\u2019s disease. Neurotox Res 30(1):88\u2013100. https:\/\/doi.org\/10.1007\/s12640-016-9618-4","journal-title":"Neurotox Res"},{"issue":"3","key":"9841_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s12031-013-0015-7","volume":"50","author":"D Brown","year":"2013","unstructured":"Brown D, Tamas A, Reglodi D, Tizabi Y (2013) PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson\u2019s disease. J Mol Neurosci 50(3):600\u2013607. https:\/\/doi.org\/10.1007\/s12031-013-0015-7","journal-title":"J Mol Neurosci"},{"issue":"3","key":"9841_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12640-014-9468-x","volume":"26","author":"D Brown","year":"2014","unstructured":"Brown D, Tamas A, Reglodi D, Tizabi Y (2014) PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson\u2019s disease. Neurotox Res 26(3):230\u2013239. https:\/\/doi.org\/10.1007\/s12640-014-9468-x","journal-title":"Neurotox Res"},{"issue":"13","key":"9841_CR7","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/hmg\/ddi178","volume":"14","author":"YC Chung","year":"2005","unstructured":"Chung YC, Seo H, Sonntag KC, Brooks A, Lin L, Isacson O (2005) Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet 14(13):1709\u20131725. https:\/\/doi.org\/10.1093\/hmg\/ddi178","journal-title":"Hum Mol Genet"},{"issue":"9","key":"9841_CR8","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/jnr.21318","volume":"85","author":"J Deguil","year":"2007","unstructured":"Deguil J, Jailloux D, Page G, Fauconneau B, Houeto JL, Philippe M, Muller JM, Pain S (2007) Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP+-induced alteration of translational control in neuro-2a neuroblastoma cells. J Neurosci Res 85(9):2017\u20132025. https:\/\/doi.org\/10.1002\/jnr.21318","journal-title":"J Neurosci Res"},{"issue":"2","key":"9841_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12640-009-9091-4","volume":"17","author":"J Deguil","year":"2010","unstructured":"Deguil J, Chavant F, Lafay-Chebassier C, P\u00e9rault-Pochat MC, Fauconneau B, Pain S (2010) Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice. Neurotox Res 17(2):142\u2013155. https:\/\/doi.org\/10.1007\/s12640-009-9091-4","journal-title":"Neurotox Res"},{"issue":"4","key":"9841_CR10","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.bbamcr.2012.02.001","volume":"1823","author":"ND Doan","year":"2012","unstructured":"Doan ND, Chatenet D, L\u00e9tourneau M, Vaudry H, Vaudry D, Fournier A (2012) Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Biochim Biophys Acta 1823(4):940\u2013949. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.02.001","journal-title":"Biochim Biophys Acta"},{"issue":"1-3","key":"9841_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12031-008-9066-6","volume":"36","author":"A Falluel-Morel","year":"2008","unstructured":"Falluel-Morel A, Tascau LI, Sokolowksi K, Braet P, DiCicco-Bloom E (2008) Granule cell survival is deficient in PAC1\u2212\/\u2212 mutant cerebellum. J Mol Neurosci 36(1-3):38\u201344. https:\/\/doi.org\/10.1007\/s12031-008-9066-6","journal-title":"J Mol Neurosci"},{"issue":"1-2","key":"9841_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0006-8993(95)00629-5","volume":"691","author":"BA Faucheux","year":"1995","unstructured":"Faucheux BA, Herrero MT, Villares J, Levy R, Javoy-Agid F, Obeso JA, Hauw JJ, Agid Y, Hirsch EC (1995) Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys. Brain Res 691(1-2):115\u2013124. https:\/\/doi.org\/10.1016\/0006-8993(95)00629-5","journal-title":"Brain Res"},{"issue":"2","key":"9841_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10253890802057221","volume":"12","author":"B Gaszner","year":"2009","unstructured":"Gaszner B, Van Wijk DC, Korosi A, Jozsa R, Roubos EW, Kozicz T (2009) Diurnal expression of period 2 and urocortin 1 in neurones of the non-preganglionic Edinger-Westphal nucleus in the rat. Stress 12(2):115\u2013124. https:\/\/doi.org\/10.1080\/10253890802057221","journal-title":"Stress"},{"issue":"1-2","key":"9841_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0169-328X(98)00202-2","volume":"61","author":"F Gillardon","year":"1998","unstructured":"Gillardon F, Hata R, Hossmann KA (1998) Delayed up-regulation of Zac1 and PACAP type I receptor after transient focal cerebral ischemia in mice. Mol Brain Res 61(1-2):207\u2013210. https:\/\/doi.org\/10.1016\/S0169-328X(98)00202-2","journal-title":"Mol Brain Res"},{"issue":"1","key":"9841_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.peptides.2012.06.004","volume":"37","author":"S Giunta","year":"2012","unstructured":"Giunta S, Castorina A, Bucolo C, Magro G, Drago F, D\u2019Agata V (2012) Early changes in pituitary adenylate cyclase activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats. Peptides 37(1):32\u201339. https:\/\/doi.org\/10.1016\/j.peptides.2012.06.004","journal-title":"Peptides"},{"issue":"2","key":"9841_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12640-009-9016-2","volume":"15","author":"K Go\u0142embiowska","year":"2009","unstructured":"Go\u0142embiowska K, Dziubina A, Kowalska M, Kami\u0144ska K (2009) Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum. Neurotox Res 15(2):155\u2013166. https:\/\/doi.org\/10.1007\/s12640-009-9016-2","journal-title":"Neurotox Res"},{"issue":"4","key":"9841_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.npep.2008.04.003","volume":"42","author":"TS Guillot","year":"2008","unstructured":"Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ, Zachrisson O, Mercer A, Miller GW (2008) PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides 42(4):423\u2013434. https:\/\/doi.org\/10.1016\/j.npep.2008.04.003","journal-title":"Neuropeptides"},{"issue":"5","key":"9841_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/jcmm.12772","volume":"20","author":"X Guo","year":"2016","unstructured":"Guo X, Yu R, Xu Y, Lian R, Yu Y, Cui Z, Ji Q, Chen J, Li Z, Liu H, Chen J (2016) PAC1R agonist maxadilan enhances hADSC viability and neural differentiation potential. J Cell Mol Med 20(5):874\u2013890. https:\/\/doi.org\/10.1111\/jcmm.12772","journal-title":"J Cell Mol Med"},{"issue":"1-3","key":"9841_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12031-008-9101-7","volume":"36","author":"N Hagino","year":"2008","unstructured":"Hagino N (2008) Performance of PAC1-R heterozygous mice in memory tasks-II. J Mol Neurosci 36(1-3):208\u2013219. https:\/\/doi.org\/10.1007\/s12031-008-9101-7","journal-title":"J Mol Neurosci"},{"issue":"2-3","key":"9841_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.schres.2015.12.016","volume":"170","author":"TB Halene","year":"2016","unstructured":"Halene TB, Kozlenkov A, Jiang Y, Mitchell AC, Javidfar B, Dincer A, Park R, Wiseman J, Croxson PL, Giannaris EL, Hof PR, Roussos P, Dracheva S, Hemby SE, Akbarian S (2016) NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure. Schizophr Res 170(2-3):235\u2013244. https:\/\/doi.org\/10.1016\/j.schres.2015.12.016","journal-title":"Schizophr Res"},{"issue":"19","key":"9841_CR21","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1212\/WNL.0000000000000417","volume":"82","author":"P Han","year":"2014","unstructured":"Han P, Liang W, Baxter LC, Yin J, Tang Z, Beach TG, Caselli RJ, Reiman EM, Shi J (2014) Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease. Neurology 82(19):1724\u20131728. https:\/\/doi.org\/10.1212\/WNL.0000000000000417","journal-title":"Neurology"},{"issue":"3","key":"9841_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jamaneurol.2014.3625","volume":"72","author":"P Han","year":"2015","unstructured":"Han P, Caselli RJ, Baxter L, Serrano G, Yin J, Beach TG, Reiman EM, Shi J (2015) Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease. JAMA Neurol 72(3):333\u2013339. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3625","journal-title":"JAMA Neurol"},{"key":"9841_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fnagi.2017.00180","volume":"9","author":"P Han","year":"2017","unstructured":"Han P, Nielsen M, Song M, Yin J, Permenter MR, Vogt JA, Engle JR, Dugger BN, Beach TG, Barnes CA, Shi J (2017) The impact of aging on brain pituitary adenylate cyclase activating polypeptide, pathology and cognition in mice and rhesus macaques. Front Aging Neurosci 9:180. https:\/\/doi.org\/10.3389\/fnagi.2017.00180","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"9841_CR24","doi-asserted-by":"publisher","first-page":"e0146981","DOI":"10.1371\/journal.pone.0146981","volume":"11","author":"J Hannibal","year":"2016","unstructured":"Hannibal J, Georg B, Fahrenkrug J (2016) Altered circadian food anticipatory activity rhythms in PACAP receptor 1 (PAC1) deficient mice. PLoS One 11(1):e0146981. https:\/\/doi.org\/10.1371\/journal.pone.0146981","journal-title":"PLoS One"},{"issue":"4","key":"9841_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0306-4522(93)90142-3","volume":"56","author":"MT Herrero","year":"1993","unstructured":"Herrero MT, Perez-Otano I, Oset C, Kastner A, Hirsch EC, Agid Y, Luquin MR, Obeso JA, Del Rio J (1993) GM-1 ganglioside promotes the recovery of surviving mid-brain dopaminergic neurons in MPTP-treated monkeys. Neuroscience 56(4):965\u2013972. https:\/\/doi.org\/10.1016\/0306-4522(93)90142-3","journal-title":"Neuroscience"},{"issue":"4","key":"9841_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0306-4522(95)00120-8","volume":"68","author":"MT Herrero","year":"1995","unstructured":"Herrero MT, Augood SJ, Hirsch EC, Javoy-Agid F, Luquin MR, Agid Y, Obeso JA, Emson PC (1995) Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 68(4):1189\u20131198. https:\/\/doi.org\/10.1016\/0306-4522(95)00120-8","journal-title":"Neuroscience"},{"issue":"1","key":"9841_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1212\/WNL.47.1.219","volume":"47","author":"MT Herrero","year":"1996","unstructured":"Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC (1996a) Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47(1):219\u2013224. https:\/\/doi.org\/10.1212\/WNL.47.1.219","journal-title":"Neurology"},{"issue":"1","key":"9841_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0169-328X(96)00157-X","volume":"42","author":"MT Herrero","year":"1996","unstructured":"Herrero MT, Augood SJ, Asensi H, Hirsch EC, Agid Y, Obeso JA, Emson PC (1996b) Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. Brain Res Mol Brain Res 42(1):149\u2013155. https:\/\/doi.org\/10.1016\/S0169-328X(96)00157-X","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"9841_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neulet.2010.08.039","volume":"484","author":"G Horvath","year":"2010","unstructured":"Horvath G, Reglodi D, Opper B, Brubel R, Tamas A, Kiss P, Toth G, Csernus V, Matkovits A, Racz B (2010) Effects of PACAP on the oxidative stress-induced cell death in chicken pinealocytes is influenced by the phase of the circadian clock. Neurosci Lett 484(2):148\u2013152. https:\/\/doi.org\/10.1016\/j.neulet.2010.08.039","journal-title":"Neurosci Lett"},{"key":"9841_CR30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1749-6632.2000.tb07002.x","volume":"921","author":"F Jamen","year":"2000","unstructured":"Jamen F, Laden JC, Bouschet T, Rodriguez-Henche N, Bockaert J, Brabet P (2000) Nerve growth factor upregulates the PA1 promoter by activating the MAP kinase pathway in rat PC12 cells. Ann N Y Acad Sci 921:390\u2013394","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"9841_CR31","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1046\/j.1471-4159.2002.01124.x","volume":"82","author":"F Jamen","year":"2002","unstructured":"Jamen F, Bouschet T, Laden JC, Bockaert J, Brabet P (2002) Up-regulation of the PACAP type-1 receptor (PAC1) promoter by neurotrophins in rat PC12 cells and mouse cerebellar granule cells via the Ras\/mitogen-activated protein kinase cascade. J Neurochem 82(5):1199\u20131207","journal-title":"J Neurochem"},{"issue":"2","key":"9841_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuroscience.2009.02.028","volume":"160","author":"V Jolivel","year":"2009","unstructured":"Jolivel V, Basille M, Aubert N, de Jouffrey S, Ancian P, Le Bigot JF, Noack P, Massonneau M, Fournier A, Vaudry H, Gonzalez BJ, Vaudry D (2009) Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience 160(2):434\u2013451. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.02.028","journal-title":"Neuroscience"},{"issue":"4","key":"9841_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/cne.20231","volume":"476","author":"KM Joo","year":"2004","unstructured":"Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI (2004) Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol 476(4):388\u2013413. https:\/\/doi.org\/10.1002\/cne.20231","journal-title":"J Comp Neurol"},{"issue":"4","key":"9841_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12640-016-9659-8","volume":"30","author":"N Kasica","year":"2016","unstructured":"Kasica N, Podlasz P, Sundvik M, Tamas A, Reglodi D, Kaleczyc J (2016) Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against oxidative stress in zebrafish hair cells. Neurotox Res 30(4):633\u2013647. https:\/\/doi.org\/10.1007\/s12640-016-9659-8","journal-title":"Neurotox Res"},{"issue":"2","key":"9841_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.410360213","volume":"36","author":"A Kastner","year":"1994","unstructured":"Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y (1994) Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy. Ann Neurol 36(2):206\u2013214. https:\/\/doi.org\/10.1002\/ana.410360213","journal-title":"Ann Neurol"},{"issue":"6","key":"9841_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","volume":"47","author":"V Kormos","year":"2013","unstructured":"Kormos V, Gaszner B (2013) Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 47(6):401\u2013419. https:\/\/doi.org\/10.1016\/j.npep.2013.10.014","journal-title":"Neuropeptides"},{"key":"9841_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.neuroscience.2016.06.004","volume":"330","author":"V Kormos","year":"2016","unstructured":"Kormos V, Gaspar L, Kovacs LA, Farkas J, Gaszner T, Csernus V, Balogh A, Hashimoto H, Reglodi D, Helyes Z, Gaszner B (2016) Reduced response to chronic mild stress in PACAP mutant mice is associated with blunted FosB expression in limbic forebrain and brainstem centers. Neuroscience 330:335\u2013358. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.06.004","journal-title":"Neuroscience"},{"key":"9841_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-94-007-4584-1_41","volume":"758","author":"SY Lam","year":"2012","unstructured":"Lam SY, Liu Y, Liong EC, Tipoe GL, Fung ML (2012) Upregulation of pituitary adenylate cyclase activating polypeptide and its receptor expression in the rat carotid body in chronic and intermittent hypoxia. Adv Exp Med Biol 758:301\u2013306. https:\/\/doi.org\/10.1007\/978-94-007-4584-1_41","journal-title":"Adv Exp Med Biol"},{"key":"9841_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuropharm.2015.05.014","volume":"108","author":"A Lamine","year":"2016","unstructured":"Lamine A, Letourneau M, Doan ND, Maucotel J, Couvineau A, Vaudry H, Chatenet D, Vaudry D, Fournier A (2016) Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model. Neuropharmacology 108:440\u2013450. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.014","journal-title":"Neuropharmacology"},{"issue":"7","key":"9841_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5483\/BMBRep.2014.47.7.086","volume":"47","author":"EH Lee","year":"2014","unstructured":"Lee EH, Seo SR (2014) Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases. BMB Rep 47(7):369\u2013375. https:\/\/doi.org\/10.5483\/BMBRep.2014.47.7.086","journal-title":"BMB Rep"},{"key":"9841_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.brainres.2010.06.048","volume":"1351","author":"JC Lee","year":"2010","unstructured":"Lee JC, Cho YJ, Kim J, Kim N, Kang BG, Cha CI, Joo KM (2010) Region-specific changes in the immunoreativity of vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide reeptors VPAC2, and PAC1 receptor in the aged rats brains. Brain Res 1351:32\u201340. https:\/\/doi.org\/10.1016\/j.brainres.2010.06.048","journal-title":"Brain Res"},{"issue":"4","key":"9841_CR42","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/stem.1915","volume":"33","author":"CH Lin","year":"2015","unstructured":"Lin CH, Chiu L, Lee HT, Chiang CW, Liu SP, Hsu YH, Lin SZ, Hsu CY, Hsieh CH, Shyu WC (2015) PACAP38\/PAC1 signaling induces bone marrow-derived cells homing to ishemic brain. Stem Cells 33(4):1153\u20131172. https:\/\/doi.org\/10.1002\/stem.1915","journal-title":"Stem Cells"},{"issue":"2","key":"9841_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1242\/dmm.027185","volume":"10","author":"G Maasz","year":"2017","unstructured":"Maasz G, Zrinyi Z, Reglodi D, Petrovics D, Rivnyak A, Kiss T, Jungling A, Tamas A, Pirger Z (2017) Pituitary adenylate cyclase-activating polypeptide (PACAP) has neuroprotective function in dopamine-based neurodegeneration developed in rat and snail parkinsonian models. Dis Model Mech 10(2):127\u2013139. https:\/\/doi.org\/10.1242\/dmm.027185","journal-title":"Dis Model Mech"},{"issue":"1","key":"9841_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12640-017-9727-8","volume":"32","author":"S Manavalan","year":"2017","unstructured":"Manavalan S, Getachew B, Manaye KF, Khundmiri SJ, Csoka AB, McKinley R, Tamas A, Reglodi D, Tizabi Y (2017) PACAP protects against ethanol and nicotine toxicity in SH-SY5Y cells: implications for drinking-smoking co-morbidity. Neurotox Res 32(1):8\u201313. https:\/\/doi.org\/10.1007\/s12640-017-9727-8","journal-title":"Neurotox Res"},{"key":"9841_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuroscience.2015.12.034","volume":"316","author":"R Marzagalli","year":"2016","unstructured":"Marzagalli R, Leggio GM, Bucolo C, Pricoco E, Keay KA, Cardile V, Castorina S, Salomone S, Drago F, Castorina A (2016) Genetic blockade of the dopamine D3 receptor enhancces hippocampal expression of PACAP and receptors and alters their cortical distribution. Neuroscience 316:279\u2013295. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.12.034","journal-title":"Neuroscience"},{"issue":"1","key":"9841_CR46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1242\/dev.116.1.201","volume":"116","author":"RJ Mullen","year":"1992","unstructured":"Mullen RJ, Buck CR, Smith AM (1992) NeuN, a neuronal specific nuclear protein in vertebrates. Development 116(1):201\u2013211","journal-title":"Development"},{"issue":"4","key":"9841_CR47","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3109\/10253890.2015.1025044","volume":"18","author":"T Mustafa","year":"2015","unstructured":"Mustafa T, Jiang SZ, Eiden AM, Weihe E, Thislethwaite I, Eiden LE (2015) Impact of PACAP and PAC1 receptor deficiency on the neurochemical and ehavioral effects of acute and chronic restraint stress in male C57BL\/6 mice. Stress 18(4):408\u2013418. https:\/\/doi.org\/10.3109\/10253890.2015.1025044","journal-title":"Stress"},{"key":"9841_CR48","doi-asserted-by":"publisher","first-page":"12034","DOI":"10.1038\/ncomms12034","volume":"7","author":"T Nakamachi","year":"2016","unstructured":"Nakamachi T, Ohtaki H, Seki T, Yofu S, Kagami N, Hashimoto H, Shintani N, Baba A, Mark L, Lanekoff I, Kiss P, Farkas J, Reglodi D, Shioda S (2016) PACAP suppresses dry eye signs by stimulating tear secretion. Nat Commun 7:12034. https:\/\/doi.org\/10.1038\/ncomms12034","journal-title":"Nat Commun"},{"issue":"1","key":"9841_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12640-015-9567-3","volume":"29","author":"BC Ndlovu","year":"2016","unstructured":"Ndlovu BC, Daniels WM, Mabandla MV (2016) Amelioration of L-dopa-associated dyskinesias with triterpenoic acid in a parkinsonian rat model. Neurotox Res 29(1):126\u2013134. https:\/\/doi.org\/10.1007\/s12640-015-9567-3","journal-title":"Neurotox Res"},{"issue":"1","key":"9841_CR50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0006-8993(95)00869-R","volume":"699","author":"M Palkovits","year":"1995","unstructured":"Palkovits M, Somogyvari-Vigh A, Arimura A (1995) Concentrations of pituitary adenylate cyclase activating polypeptide (PACAP) in human brain nuclei. Brain Res 699(1):116\u2013120. https:\/\/doi.org\/10.1016\/0006-8993(95)00869-R","journal-title":"Brain Res"},{"issue":"11","key":"9841_CR51","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/gerona\/glu068","volume":"69","author":"Z Pirger","year":"2014","unstructured":"Pirger Z, Naskar S, Laszlo Z, Kemenes G, Reglodi D, Kemenes I (2014) Reversal of age-related learning deficiency by the vertebrate PACAP and IGF-1 in a novel invertebrate model of aging: the pond snail (Lymnaea stagnalis). J Gerontol A Biol Sci Med Sci 69(11):1331\u20131338. https:\/\/doi.org\/10.1093\/gerona\/glu068","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1-3","key":"9841_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.regpep.2009.12.003","volume":"160","author":"B Racz","year":"2010","unstructured":"Racz B, Horvath G, Reglodi D, Gasz B, Kiss P, Gallyas F Jr, Sumegi B, Toth G, Nemeth A, Lubics A, Tamas A (2010) PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study. Regul Pept 160(1-3):91\u201398. https:\/\/doi.org\/10.1016\/j.regpep.2009.12.003","journal-title":"Regul Pept"},{"issue":"1-2","key":"9841_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbr.2003.09.007","volume":"151","author":"D Reglodi","year":"2004","unstructured":"Reglodi D, Lubics A, Tamas A, Szalontay L, Lengvari I (2004) Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson\u2019s disease. Behav Brain Res 151(1-2):303\u2013312. https:\/\/doi.org\/10.1016\/j.bbr.2003.09.007","journal-title":"Behav Brain Res"},{"issue":"4","key":"9841_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.npep.2006.06.001","volume":"40","author":"D Reglodi","year":"2006","unstructured":"Reglodi D, Lubics A, Kiss P, Lengvari I, Gaszner B, Toth G, Hegyi O, Tamas A (2006a) Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats. Neuropeptides 40(4):265\u2013274. https:\/\/doi.org\/10.1016\/j.npep.2006.06.001","journal-title":"Neuropeptides"},{"issue":"1","key":"9841_CR55","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1196\/annals.1317.072","volume":"1070","author":"D Reglodi","year":"2006","unstructured":"Reglodi D, Tamas A, Lengvari I, Toth G, Szalontay L, Lubics A (2006b) Comparative study on the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson\u2019s disease. Ann N Y Acad Sci 1070(1):518\u2013524. https:\/\/doi.org\/10.1196\/annals.1317.072","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"9841_CR56","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2174\/138161211795589355","volume":"17","author":"D Reglodi","year":"2011","unstructured":"Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review of the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17(10):962\u2013972. https:\/\/doi.org\/10.2174\/138161211795589355","journal-title":"Curr Pharm Des"},{"issue":"3","key":"9841_CR57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s12031-012-9762-0","volume":"48","author":"D Reglodi","year":"2012","unstructured":"Reglodi D, Kiss P, Szabadfi K, Atlasz T, Gabriel R, Horvath G, Szakaly P, Sandor B, Lubics A, Laszlo E, Farkas J, Matkovits A, Brubel R, Hashimoto H, Ferencz A, Vincze A, Zs H, Welke L, Lakatos A, Tamas A (2012) PACAP is an endogenous protective factor\u2014insights from PACAP deficient mice. J Mol Neurosci 48(3):482\u2013492. https:\/\/doi.org\/10.1007\/s12031-012-9762-0","journal-title":"J Mol Neurosci"},{"key":"9841_CR58","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.10.004","volume":"155","author":"D Reglodi","year":"2017","unstructured":"Reglodi D, Renaud J, Tamas A, Tizabi Y, Soc\u00edas SB, Del-Bel E, Raisman-Vozari R (2017) Novel tactics for neuroprotection in Parkinson\u2019s disease: role of antibiotics, polyphenols and neuropeptides. Prog Neurobiol 155:120\u2013148. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.10.004","journal-title":"Prog Neurobiol"},{"issue":"7335","key":"9841_CR59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature09856","volume":"470","author":"KJ Ressler","year":"2011","unstructured":"Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm SD, Kilaru V, Smith AK, Myers AJ, Ramirez M, Engel A, Hammack SE, Toufexis D, Braas KM, Binder EB, May V (2011) Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470(7335):492\u2013497. https:\/\/doi.org\/10.1038\/nature09856","journal-title":"Nature"},{"key":"9841_CR60","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neuroscience.2016.07.011","volume":"333","author":"Z Richter","year":"2016","unstructured":"Richter Z, Janszky J, S\u00e9t\u00e1l\u00f3 G Jr, Horv\u00e1th R, Horv\u00e1th Z, D\u00f3czi T, Seress L, \u00c1brah\u00e1m H (2016) Characterization of neurons in the cortical white matter in human temporal lobe epilepsy. Neuroscience 333:140\u2013150. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.07.011","journal-title":"Neuroscience"},{"issue":"3","key":"9841_CR61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12640-015-9519-y","volume":"27","author":"J Segura-Aguilar","year":"2015","unstructured":"Segura-Aguilar J, Kostrzewa RM (2015) Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update. Neurotox Res 27(3):328\u2013354. https:\/\/doi.org\/10.1007\/s12640-015-9519-y","journal-title":"Neurotox Res"},{"key":"9841_CR62","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.peptides.2015.08.006","volume":"72","author":"S Shioda","year":"2015","unstructured":"Shioda S, Nakamachi T (2015) PACAP as a neuroprotective factor in ischemic neuronal injuries. Peptides 72:202\u2013207. https:\/\/doi.org\/10.1016\/j.peptides.2015.08.006","journal-title":"Peptides"},{"issue":"9","key":"9841_CR63","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.bbadis.2014.06.020","volume":"1842","author":"KY Shivers","year":"2014","unstructured":"Shivers KY, Nikolopoulou A, Machlovi SI, Vallabhajosula S, Figueiredo-Pereira ME (2014) PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. Biochim Biophys Acta 1842(9):1707\u20131719. https:\/\/doi.org\/10.1016\/j.bbadis.2014.06.020","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9841_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12640-016-9612-x","volume":"30","author":"O Solis","year":"2016","unstructured":"Solis O, Garc\u00eda-Sanz P, Herranz AS, Asensio MJ, Moratalla R (2016) L-DOPA reverses the increased free amino acids tissue levels induced by dopamine depletion and rises GABA and tyrosine in the striatum. Neurotox Res 30(1):67\u201375. https:\/\/doi.org\/10.1007\/s12640-016-9612-x","journal-title":"Neurotox Res"},{"issue":"23","key":"9841_CR65","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2174\/1381612043383548","volume":"10","author":"A Somogyvari-Vigh","year":"2004","unstructured":"Somogyvari-Vigh A, Reglodi D (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Review. Curr Pharm Des 10(23):2861\u20132889. https:\/\/doi.org\/10.2174\/1381612043383548","journal-title":"Curr Pharm Des"},{"issue":"4","key":"9841_CR66","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/j.1471-4159.2007.04895.x","volume":"103","author":"R Stumm","year":"2007","unstructured":"Stumm R, Kolodziej A, Prinz V, Endres M, Wu DF, Hollt V (2007) Pituitary adenylate cyclase activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from hypoxia\/ischemic damage. J Neurochem 103(4):1666\u20131681. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04895.x","journal-title":"J Neurochem"},{"issue":"1","key":"9841_CR67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0169-328X(03)00172-4","volume":"115","author":"R Suzuki","year":"2003","unstructured":"Suzuki R, Arata S, Nakajo S, Ikenaka K, Kikuyama S, Shioda S (2003) Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. Brain Res Mol Brain Res 115(1):10\u201320. https:\/\/doi.org\/10.1016\/S0169-328X(03)00172-4","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"9841_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00441-012-1349-0","volume":"348","author":"K Szabadfi","year":"2012","unstructured":"Szabadfi K, Atlasz T, Kiss P, Reglodi D, Szabo A, Kovacs K, Szalontai B, Setalo G Jr, Banki E, Csanaky K, Tamas A, Gabriel R (2012) Protective effects of the neuropeptide PACAP in diabetic retinopathy. Cell Tissue Res 348(1):37\u201346. https:\/\/doi.org\/10.1007\/s00441-012-1349-0","journal-title":"Cell Tissue Res"},{"issue":"3","key":"9841_CR69","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12640-015-9593-1","volume":"29","author":"K Szabadfi","year":"2016","unstructured":"Szabadfi K, Reglodi D, Szabo A, Szalontai B, Valasek A, Setalo G Jr, Kiss P, Tamas A, Wilhelm M, Gabriel R (2016) Pituitary adenylate cyclase activating polypeptide, a potential therapeutic agent for diabetic retinopathy in rats: focus on the vertical information processing pathway. Neurotox Res 29(3):432\u2013446. https:\/\/doi.org\/10.1007\/s12640-015-9593-1","journal-title":"Neurotox Res"},{"issue":"5","key":"9841_CR70","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5","volume":"54","author":"N Takei","year":"1998","unstructured":"Takei N, Skoglosa Y, Lindholm D (1998) Neurotrophic and neuroprotective effects of pituitary adenylate cyclase activating polypeptide (PACAP) on mesencephalic dopaminergic neurons. J Neurosci Res 54(5):698\u2013706. https:\/\/doi.org\/10.1002\/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5","journal-title":"J Neurosci Res"},{"issue":"12","key":"9841_CR71","doi-asserted-by":"publisher","first-page":"8430","DOI":"10.3390\/ijms13078430","volume":"13","author":"A Tamas","year":"2012","unstructured":"Tamas A, Reglodi D, Farkas O, Kovesdi E, Pal J, Povlishock JT, Schwarcz A, Czeiter E, Szanto Z, Doczi T, Buki A, Bukovics P (2012) Effects of PACAP in central and peripheral nerve injuries. Int J Mol Sci 13(12):8430\u20138448. https:\/\/doi.org\/10.3390\/ijms13078430","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9841_CR72","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.mvr.2012.08.004","volume":"84","author":"D Tripathy","year":"2012","unstructured":"Tripathy D, Sanchez A, Yin X, Martinez J, Grammas P (2012) Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen. Microvasc Res 84(3):278\u2013285. https:\/\/doi.org\/10.1016\/j.mvr.2012.08.004","journal-title":"Microvasc Res"},{"issue":"2","key":"9841_CR73","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12031-016-0818-4","volume":"60","author":"A Vaczy","year":"2016","unstructured":"Vaczy A, Reglodi D, Somoskeoy T, Kovacs K, Lokos E, Szabo E, Tamas A, Atlasz T (2016) The protective role of PAC1-receptor agonist maxadilan in BCCAO-induced retinal degeneration. J Mol Neurosci 60(2):186\u2013194. https:\/\/doi.org\/10.1007\/s12031-016-0818-4","journal-title":"J Mol Neurosci"},{"issue":"3","key":"9841_CR74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61(3):283\u2013357. https:\/\/doi.org\/10.1124\/pr.109.001370","journal-title":"Pharmacol Rev"},{"issue":"18","key":"9841_CR75","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1016\/j.febslet.2005.06.013","volume":"579","author":"G Wang","year":"2005","unstructured":"Wang G, Qi C, Fan GH, Zhou HY, Chen SD (2005) PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone. FEBS Lett 579(18):4005\u20134011. https:\/\/doi.org\/10.1016\/j.febslet.2005.06.013","journal-title":"FEBS Lett"},{"issue":"3","key":"9841_CR76","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.npep.2008.03.002","volume":"42","author":"G Wang","year":"2008","unstructured":"Wang G, Pan J, Tan YY, Sun XK, Zhang YF, Zhou HY, Ren RJ, Wang XJ, Chen SD (2008) Neuroprotective effects of PACAP27 in mice model of Parkinson\u2019s disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum. Neuropeptides 42(3):267\u2013276. https:\/\/doi.org\/10.1016\/j.npep.2008.03.002","journal-title":"Neuropeptides"},{"key":"9841_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuroscience.2013.03.002","volume":"240","author":"MB Watson","year":"2013","unstructured":"Watson MB, Nobuta H, Abad C, Lee SK, Bala N, Zhu C, Richter F, Chesselet MF, Waschek JA (2013) PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice. Neuroscience 240:277\u2013286. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.03.002","journal-title":"Neuroscience"},{"issue":"2","key":"9841_CR78","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1515\/cmble-2015-0008","volume":"20","author":"R Yang","year":"2015","unstructured":"Yang R, Jiang X, Ji R, Meng L, Liu F, Chen X, Xin Y (2015) Therapeutic potential of PACAP for neurodegenerative diseases. Cell Mol Biol Lett 20(2):265\u2013278. https:\/\/doi.org\/10.1515\/cmble-2015-0008","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"9841_CR79","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12031-016-0757-0","volume":"59","author":"\u0130H Yelkenli","year":"2016","unstructured":"Yelkenli \u0130H, Ulupinar E, Korkmaz OT, \u015eener E, Ku\u015f G, Filiz Z, Tun\u00e7el N (2016) Modulation of corpus striatal neurochemistry by astrocytes and vasoactive intestinal peptide (VIP) in parkinsonian rats. J Mol Neurosci 59(2):280\u2013289. https:\/\/doi.org\/10.1007\/s12031-016-0757-0","journal-title":"J Mol Neurosci"},{"issue":"12","key":"9841_CR80","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00702-004-0175-2","volume":"111","author":"M Zink","year":"2004","unstructured":"Zink M, Schmitt A, Henn FA, Gass P (2004) Differential expression of glutamate transporters EAAT1 and EAAT2 in mice deficient for PACAP-type I receptor. J Neural Transm (Vienna) 111(12):1537\u20131542. https:\/\/doi.org\/10.1007\/s00702-004-0175-2","journal-title":"J Neural Transm (Vienna)"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-017-9841-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9841-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9841-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T04:37:53Z","timestamp":1660106273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-017-9841-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["9841"],"URL":"https:\/\/doi.org\/10.1007\/s12640-017-9841-7","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}